Dexmethylphenidate

This classification denotes a cns stimulant with the molecular formula C14H19NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) M32RH9MFGP, chemically known as 2-piperidineacetic acid, alpha-phenyl-, methyl ester, threo- but more generally known as dexmethylphenidate, which bears US NIH Compound Identifier 154101. European Medicines Agency schedules Dexmethylphenidate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30294. The term DEXMETHYLPHENIDATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 17, No. 4, 2003, List 50). World Health Organization schedules dexmethylphenidate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule dexmethylphenidate under HS 29333999 and SITC 51574. As of Q4 2014, DEXMETHYLPHENIDATE remains US FDA's Preferred Term for this commodity. Dexmethylphenidate bears US NLM identifiers UMLS ID C1169997 and NCI Concept Code C26642. SMILES: O(C(=O)C(C1NCCCC1)C1CCCCC1)C.